Satellos Bioscience Stock Performance

MSCLF Stock  USD 11.50  0.23  2.04%   
On a scale of 0 to 100, Satellos Bioscience holds a performance score of 16. The entity has a beta of 0.26, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Satellos Bioscience's returns are expected to increase less than the market. However, during the bear market, the loss of holding Satellos Bioscience is expected to be smaller as well. Please check Satellos Bioscience's expected short fall, and the relationship between the value at risk and daily balance of power , to make a quick decision on whether Satellos Bioscience's existing price patterns will revert.

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Satellos Bioscience are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Satellos Bioscience reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow717.5 K
Total Cashflows From Investing Activities1.7 M
  

Satellos Bioscience Relative Risk vs. Return Landscape

If you would invest  670.00  in Satellos Bioscience on November 17, 2025 and sell it today you would earn a total of  480.00  from holding Satellos Bioscience or generate 71.64% return on investment over 90 days. Satellos Bioscience is currently producing 0.9875% returns and takes up 4.8508% volatility of returns over 90 trading days. Put another way, 43% of traded otc stocks are less volatile than Satellos, and 81% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Satellos Bioscience is expected to generate 6.35 times more return on investment than the market. However, the company is 6.35 times more volatile than its market benchmark. It trades about 0.2 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of risk.

Satellos Bioscience Target Price Odds to finish over Current Price

The tendency of Satellos OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 11.50 90 days 11.50 
about 5.62
Based on a normal probability distribution, the odds of Satellos Bioscience to move above the current price in 90 days from now is about 5.62 (This Satellos Bioscience probability density function shows the probability of Satellos OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Satellos Bioscience has a beta of 0.26. This indicates as returns on the market go up, Satellos Bioscience average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Satellos Bioscience will be expected to be much smaller as well. Additionally Satellos Bioscience has an alpha of 0.962, implying that it can generate a 0.96 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Satellos Bioscience Price Density   
       Price  

Predictive Modules for Satellos Bioscience

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Satellos Bioscience. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
6.6511.5016.35
Details
Intrinsic
Valuation
LowRealHigh
3.718.5613.41
Details

Satellos Bioscience Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Satellos Bioscience is not an exception. The market had few large corrections towards the Satellos Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Satellos Bioscience, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Satellos Bioscience within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.96
β
Beta against Dow Jones0.26
σ
Overall volatility
2.35
Ir
Information ratio 0.19

Satellos Bioscience Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Satellos Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Satellos Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Satellos Bioscience appears to be risky and price may revert if volatility continues
Net Loss for the year was (15.51 M) with loss before overhead, payroll, taxes, and interest of (793.97 K).
Satellos Bioscience has accumulated about 1.93 M in cash with (5.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.

Satellos Bioscience Fundamentals Growth

Satellos OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Satellos Bioscience, and Satellos Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Satellos OTC Stock performance.

About Satellos Bioscience Performance

By analyzing Satellos Bioscience's fundamental ratios, stakeholders can gain valuable insights into Satellos Bioscience's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Satellos Bioscience has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Satellos Bioscience has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Satellos Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Things to note about Satellos Bioscience performance evaluation

Checking the ongoing alerts about Satellos Bioscience for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Satellos Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Satellos Bioscience appears to be risky and price may revert if volatility continues
Net Loss for the year was (15.51 M) with loss before overhead, payroll, taxes, and interest of (793.97 K).
Satellos Bioscience has accumulated about 1.93 M in cash with (5.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Evaluating Satellos Bioscience's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Satellos Bioscience's otc stock performance include:
  • Analyzing Satellos Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Satellos Bioscience's stock is overvalued or undervalued compared to its peers.
  • Examining Satellos Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Satellos Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Satellos Bioscience's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Satellos Bioscience's otc stock. These opinions can provide insight into Satellos Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Satellos Bioscience's otc stock performance is not an exact science, and many factors can impact Satellos Bioscience's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Satellos OTC Stock analysis

When running Satellos Bioscience's price analysis, check to measure Satellos Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Satellos Bioscience is operating at the current time. Most of Satellos Bioscience's value examination focuses on studying past and present price action to predict the probability of Satellos Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Satellos Bioscience's price. Additionally, you may evaluate how the addition of Satellos Bioscience to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.